BOT 4.35% 36.0¢ botanix pharmaceuticals ltd

Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus, page-166

  1. 7,647 Posts.
    lightbulb Created with Sketch. 618
    yeah but if the end points were not met the share price of, this stock would have easily gone half or even down to 80% as we have seen after the failure of the previous trial results.

    Now we have achieved the end points and the trial is success why the opposite is not happening. It is a Bio Tech stock FFS , not a gold explorer, the share price should be up atleast 100% after these results.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
36.0¢
Change
0.015(4.35%)
Mkt cap ! $651.6M
Open High Low Value Volume
34.5¢ 36.5¢ 34.5¢ $1.231M 3.443M

Buyers (Bids)

No. Vol. Price($)
2 156338 35.5¢
 

Sellers (Offers)

Price($) Vol. No.
36.5¢ 444065 17
View Market Depth
Last trade - 16.10pm 22/08/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.